Company intelligence

Khartis Therapeutics

Recent changes

  1. Aug 13, 2026Raised $50M Series B Axios
  2. Aug 13, 2026New investor: Foresite Capital Axios
  3. Aug 13, 2026New investor: Nextech Invest Axios

Funding History

1 event ยท sources dated per row
DateEventAmountValuationInvestorsSource
Aug 13, 2026Series B$50Mโ€”
Foresite CapitalunverifiedLilly Asia VenturesunverifiedNextech InvestunverifiedForge Life Science Partners
Pulse story

Investors

Latest Pulse

  1. Khartis Emerges From Stealth With $95M for a Thyroid PillKhartis Therapeutics emerged from stealth with $95 million in total funding, including a new $50 million Series B, to develop an oral alternative to injectable treatments for thyroid eye disease.โ†’

Coverage Timeline

newest first
  1. Aug 13, 2026FUNDINGKhartis Emerges From Stealth With $95M for a Thyroid Pill$50M Series Bโ†’

All Coverage

Related Companies

Khartis Therapeutics FAQ

Who are Khartis Therapeutics's investors?

Khartis Therapeutics's investors include Foresite Capital, Lilly Asia Ventures, Nextech Invest.

Sources & methodologyshow
Where these figures come from

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data ยท Suggest a correction